New 3-in-1 pill releases Parkinson’s drugs over a 24-hour period

News

Author: Parkinson's Life editorsPublished: 17 February 2016

Prep: Cook: Serves:

A new pill containing three drugs used to treat Parkinson’s disease has been developed by scientists at Nanyang Technology University (NTU) in Singapore. The pill is designed to release the medication slowly over a 24-hour period, which can reduce the number of times multiple Parkinson’s tablets have to be administered, benefitting patients and carers.

The new technology uses a patented micro-encapsulation process and is being tested in animal models.

Professor Ivy Ng, group CEO of SingHealth said: “This disease can be treated, but with three types of drugs that have to be taken three times a day. This can prove difficult and challenging for our elderly patients. NTU materials science engineers are working with our (National) Neuroscience Institute to look at how nano-medicine can package these three drugs into one pill that needs to be taken maybe just once a day, slowly releasing the medication over 24 to 48 hours.”

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

Fighting Fit: tackling Parkinson’s in the workplace

We talk to the founders of a new programme in Buckinghamshire, UK

Game on: your invite to Parkinson’s football ‘World Cup’

Forget Euro 2016 and the Copa, there’s another tournament in town

Walk with Copenhagen

Join the Danish Parkinson Association for their annual event

Sir Billy Connolly: Parkinson’s disease is “like a strange animal”

Scottish comedian, actor and musician Sir Billy Connolly has recently discussed his experience of Parkinson’s disease while promoting his new autobiography, ‘Windswept & Interesting’. In an appearance on UK talk show, ‘The Graham Norton Show’, the comedian explained that he had lost the ability to write. He said: “It breaks my heart as I used to love writing letters to people.” Speaking to UK newspaper The Guardian, Connolly added that he thinks the condition is “like a strange animal. One that sits beside you and says, ‘How will you get on without this?’ – before it takes away something else.” Despite these adjustments, Connolly told Norton he has “good days and bad days” with the condition. “It’s creeping up on me and it never lets go,” he said. “I walk like a drunk man and have to have help. So, life is different, but it is good.” Lead image credit:…

New insights on immune cell process and Parkinson’s disease

Insoluble clumps of the protein alpha-synuclein, which can cause damage to brain cells, have been previously linked to Parkinson’s. Now, scientists in Germany, France and the US have uncovered new details on how brain cells respond to these clusters. The researchers discovered that the brain’s immune cells may be able to join together to break down the protein clumps. According to a press release, this was previously unknown. They also found that these neighbouring cells share mitochondria – structures that generate energy for chemical reactions – to help one another. In certain mutations associated with Parkinson’s, this process may be impaired. The researchers hope this insight could inform the development of new therapies. “We have opened the door to a field that will certainly engage researchers for many years to come,” said Professor Dr Michael Heneka, director of the Department of Neurodegenerative Diseases and Geriatric Psychiatry at the University Hospital…

Could analysing skin oil help diagnose Parkinson’s disease?

Parkinson’s disease patients tend to have high levels of oil, known as sebum, on their skin’s surface. Now, a study has suggested that analysing this substance may help when diagnosing the condition. The study revealed that sebum contains significant amounts of genetic material, specifically the molecule ribonucleic acid (RNA). Analysis of RNA contained in sebum – that is, skin surface lipids RNA, or SSL-RNA – could offer insights into a person’s health. Researchers in Japan examined SSL-RNA in men and women with and without Parkinson’s. The results suggested that the SSL-RNA profiles of those with Parkinson’s had “different characteristics” than those without. The researchers then tested whether examining these profiles with machine learning could reveal those who had Parkinson’s – and who didn’t. The team’s algorithm indicated a “relatively robust discriminatory ability,” supporting the further use of SSL-RNA as part of a future “non-invasive” method for diagnosis.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

New 3-in-1 pill releases Parkinson’s drugs over a 24-hour period

News

Author: Parkinson's Life editorsPublished: 17 February 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

Fighting Fit: tackling Parkinson’s in the workplace

Health & Fitness

Game on: your invite to Parkinson’s football ‘World Cup’

Europe

Walk with Copenhagen

Sir Billy Connolly: Parkinson’s disease is “like a strange animal”

New insights on immune cell process and Parkinson’s disease

Could analysing skin oil help diagnose Parkinson’s disease?

{title}

Subscribe

New 3-in-1 pill releases Parkinson’s drugs over a 24-hour period

News

Author: Parkinson's Life editorsPublished: 17 February 2016

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

Fighting Fit: tackling Parkinson’s in the workplace

Health & Fitness

Game on: your invite to Parkinson’s football ‘World Cup’

Europe

Walk with Copenhagen

Sir Billy Connolly: Parkinson’s disease is “like a strange animal”

New insights on immune cell process and Parkinson’s disease

Could analysing skin oil help diagnose Parkinson’s disease?

{title}

Subscribe

Sign in